Prudential Financial
ADCT icon

Prudential Financial’s ADC Therapeutics ADCT Stock Holding History

Prudential Financial’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Sell
14,295
-12,000
-46% -$35K ﹤0.01% 2477
2026
Q1 		$98.6K Buy
+26,295
New +$104K ﹤0.01% 2235
2025
Q1 		– Sell
-17,430
Closed -$34.7K – 2286
2024
Q4 		$34.7K Buy
+17,430
New +$45.6K ﹤0.01% 2240

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Prudential Financial's ADCT Position: Q2 2026 in Review

Prudential Financial reduced its ADC Therapeutics (ADCT) stake by 46% in Q2 2026, selling an estimated $35K and leaving 14,295 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2477.

Prudential Financial first reported a position in ADCT in Q4 2024 and has held it in 3 quarters since. The position peaked at $98.6K in Q1 2026. 114 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • Prudential Financial held 14,295 shares of ADC Therapeutics worth $15.3K as of Q2 2026.
  • Prudential Financial sold 12,000 ADC Therapeutics shares in Q2 2026, an estimated $35K.
  • ADC Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2477 holding.
  • Prudential Financial first reported a position in ADC Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Prudential Financial's ADC Therapeutics position peaked at $98.6K in Q1 2026.
  • 114 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.